期刊
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK
卷 15, 期 8, 页码 989-997出版社
HARBORSIDE PRESS
DOI: 10.6004/jnccn.2017.0132
关键词
-
类别
资金
- Astellas
- AstraZeneca
- Celldex Therapeutics
- Clovis Oncology
- Genomic Health, Inc.
- Kyowa Hakko Kirin
- Jazz Pharmaceuticals
- Novartis Pharmaceuticals Corporation
- NOVOCURE
- Merck Co., Inc.
The NCCN Guidelines for Palliative Care provide interdisciplinary recommendations on palliative care for patients with cancer. These NCCN Guidelines Insights summarize and provide context for the updated guidelines recommendations regarding hospice and end-of-life (EOL) care. Updates for 2017 include revisions to and restructuring of the algorithms that address important EOL concerns. These recommendations were revised to provide clearer guidance for oncologists as they care for patients with cancer who are approaching the transition to EOL care. Recommendations for interventions and reassessment based on estimated life expectancy were streamlined and reprioritized to promote hospice referrals and improved EOL care.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据